Morpholino

MO5-dnmt1

ID

ZDB-MRPHLNO-120517-15

Name

MO5-dnmt1

Previous Names

Target

Sequence

5' - TGAGGTCTTGGTAGGCATTTCAAGT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO5-dnmt1

No data available

Phenotype

Phenotype resulting from MO5-dnmt1

No data available

Phenotype of all Fish created by or utilizing MO5-dnmt1

Phenotype	Fish	Conditions	Figures
intrahepatic bile duct development arrested, abnormal	TL + MO5-dnmt1 + MO6-dnmt1	standard conditions	Fig. 2 from Matthews et al., 2011
bile ductule morphology, abnormal	TL + MO5-dnmt1 + MO6-dnmt1	standard conditions	Fig. 2 from Cofer et al., 2016
intrahepatic bile duct development disrupted, abnormal	TL + MO5-dnmt1 + MO6-dnmt1	standard conditions	Fig. 2 from Cofer et al., 2016
intrahepatic bile duct decreased branchiness, abnormal	TL + MO5-dnmt1 + MO6-dnmt1	standard conditions	Fig. 2 from Matthews et al., 2011
bile ductule morphology, ameliorated	TL + MO5-dnmt1 + MO6-dnmt1	chemical treatment: Cyclopamine	Fig. 2 from Cofer et al., 2016
gall bladder decreased functionality, abnormal	TL + MO5-dnmt1 + MO6-dnmt1	standard conditions	Fig. 2 from Matthews et al., 2011
DNA (cytosine-5-)-methyltransferase activity increased occurrence, abnormal	TL + MO5-dnmt1 + MO6-dnmt1	standard conditions	Fig. S1 from Matthews et al., 2011
bile ductule degenerate, abnormal	TL + MO5-dnmt1 + MO6-dnmt1	standard conditions	Fig. 2 from Matthews et al., 2011
hepatocyte increased size, abnormal	TL + MO5-dnmt1 + MO6-dnmt1	standard conditions	Fig. 2 from Matthews et al., 2011

Citations